Major Depressive Disorder in Adolescence: A Brief Review of the Recent Treatment Literature

Canadian Journal of Psychiatry

Volumn 48, Issue 9, 2003, Pages 600-606

  Milin, Robert ^a   Walker, Selena ^a   Chow, Joy ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Adolescence; Major depressive disorder; Pharmacotherapy; Psychosocial treatment; Review

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADOLESCENT DISEASE; BEHAVIOR THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DRUG EFFICACY; DRUG RESPONSE; ELECTROCONVULSIVE THERAPY; FAMILY THERAPY; HUMAN; INTERPERSONAL THERAPY; LOW DRUG DOSE; MAJOR DEPRESSION; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; RELAPSE; REVIEW; SIDE EFFECT; SUDDEN DEATH;

EID: 0242679522     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800906     Document Type: Review

References (85)

1. Fleming JE, Offord DR, Boyle MH. Prevalence of childhood and adolescent depression the community. Ontario child health study. Br J Psychiatry 1989;155:647-54.
2. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the national comorbidity survey. Depress Anxiety 1998;7:3-14.
3. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kauffman J, Dahl RE, and others. Childhood and adolescent depression: a review of the past 10 years. Part 1. J Am Acad Child Adolesc Psychiatry 1996;35:1427-39.
4. Lewinsohn P, Roberts R, Seeley J, Rohde P, Gotlib I, Hops H. Adolescent psychopathology, II: psychosocial risk factors for depression. J Abnorm Psychol 1994;103:302-15.
5. Strober M. Familial aspects of depressive disorder in early adolescence. In: Weller EB, Weller RA, editors. An update of childhood depression. Washington (DC): APA Press; 1984. p 38-48.
6. Bland RC, Newman SC, Orn H. Recurrent and nonrecurrent depression. A family study. Arch Gen Psychiatry 1986;43:1085-9.
7. Kupfer DJ, Frank E, Carpenter LL, Neiswanger K. Family history in recurrent depression. J Affect Disord 1989;17:113-9.
8. Marazita ML, Neiswanger K, Cooper M, Zubenko GS, Giles DE, Frank E, and others. Genetic segregation analysis of early-onset recurrent unipolar depression. Am J Hum Genet 1997;61:1370-8.
9. Merikangas KR, Risch NJ, Weissman MM. Comorbidity and co-transmission of alcoholism, anxiety and depression. Psychol Med 1994;24:69-80.
10. Weissman MM, Leckman JF, Meikangas KR, Gammon GD, Prusoff BA. Depression and anxiety disorders in parents and children. Results from the Yale family study. Arch Gen Psychiatry 1984;41:845-52.
11. Williamson DE, Ryan ND, Birmaher B, Dahl RE, Kaufman J, Rao U, and others. A case-control family history study of depression in adolescents. J Am Acad Child Adolesc Psychiatry 1995;34:1596-1607.
12. Mitchell J, McCauley E, Burke P. Psychopathology in parents of depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 1989;28:352-7.
13. Puig-Antich J, Goetz D, Davies M, Kaplan T, Davies S, Ostrow L, and others. A controlled family history study of prepubertal major depression disorder. Arch Gen Psychiatry 1989;46:406-18.
14. Weller RA, Kapadia P, Weller EB, Fristad M, Lazaroff LB, Preskorn SH. Psychopathology in families of children with major depressive disorders. J Affect Disord 1994;31:247-52.
15. Klein DN, Lewinsohn PM, Seeley JR, Rohde P. A family study of major depressive disorder in a community sample of adolescents. Arch Gen Psychiatry 2001;58:13-20.
16. Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996;35:701-15.
17. Roberts RE, Lewinsohn PM, Seeley JR. Symptoms of DSM-III-R major depression in adolescence: Evidence from an epidemiological survey. J Am Acad Child Adolesc Psychiatry 1995;34:1608-17.
18. Carlson GA, Kashani JH. Phenomenology of major depression from childhood through adulthood: analysis of three studies. Am J Psychiatry 1988;145:1222-5.
19. Ryan N, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, and others. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 1987;44:854-61.
20. Jaffe SE, Moffitt TE, Caspi A, Fombonne E, Poulton R, Martin J. Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry 2002;59:215-22.
21. Harrington RC, Fudge H, Rutter M, Pickles A, Hill J. Adult outcomes of childhood and adolescent depression: I. Psychiatric status. Arch Gen Psychiatry 1990;47:465-73.
22. Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R. Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984;41:643-9.
23. Simeon JG. Depressive disorders in children and adolescents. Psychiatr J Univ Ott 1989;14:356-61.
24. Goodyer IM, Herbert J, Secher SM, Pearson J. Short-term outcome of major depression: I comorbidity and severity at presentation as predictors of persistent disorder. J Am Acad Child Adolesc Psychiatry 1997;36:179-87.
25. Kaminski KM, Garber J. Depressive spectrum disorders in high-risk adolescents: episode duration and predictors of time to recovery. J Am Acad Child Adolesc Psychiatry 2002;41:410-8.
26. Goodyer IM, Herbert J, Tamplin A, Secher SM, Pearson J. Short-term outcome of major depression: II life events, family dysfunction, and friendship difficulties as predictors of persistent disorder. J Am Acad Child Adolesc Psychiatry 1997;36:474-80.
27. King CA, Ghaziuddin N, McGovern L, Brand E, Hill E, Naylor M. Predictors of comorbid alcohol and substance abuse in depressed adolescents. J Am Acad Child Adolesc Psychiatry 1996;35:745-51.
28. King CA, Naylor M, Hill E, Shain B, Greden J. Dysthymia characteristic of heavy alcohol use in depressed adolescents. Biol Psychiatry 1993;33:210-2.
29. Brent DA, Perper JA, Moritz G, Allman C, Friend A, Roth C, and others. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry 1993;32:521-9.
30. Ambrosini PJ, Bianchi M, Metz C, Rabinovich H. Evaluating clinical response of open nortriptyline pharmacotherapy in adolescent major depression. J Child Adolesc Psychopharmacol 1994;4:233-44.
31. Ryan N, Puig-Antich J, Cooper T, Rabinovich H, Ambrosini P, Davies M, and others. Imipramine in adolescent depression: plasma level and clinical response. Acta Psychiatr Scand 1986;73:275-88.
32. Strober M, Freeman R, Rigali J. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine. Psychopharmacol Bull 1990;26:80-4.
33. Boulos C, Kutcher S, Gardner D, Young E. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol 1992;2:103-11.
34. Colle L, Belair J-F, DiFeo M, Weiss J, LaRoche C. Extended open-label fluoxetine treatment of adolescents with major depression. J Child Adolescent Psychopharmacol 1994;4:225-32.
35. McConville B, Minnery K, Sorter M, West S, Friedman L, Christian K. An open study of the effects of sertraline on adolescent major depression. J Child Adolesc Psychopharmacol 1996;6:41-51.
36. Nixon MK, Milin R, Simeon, JG, Cloutier P, Spenst W. Sertraline effects in adolescent major depression and dysthymia: A 6-month open trial. J Child Adolesc Psychopharmacol 2001;11:131-42.
37. Ambrosini PJ, Wagner KD, Biederman J, Glick I, Tan C, Elia J, and others. Multicenter open-label sertraline study in adolescent outpatients with major depression. J Am Acad Child Adolesc Psychiatry 1999;38:566-72.
38. Rey-Sanchez F, Gutierrez-Casares J. Paroxetine in children with major depressive disorder: an open trial. J Am Acad Child Adolesc Psychiatry 1997;36:1443-7.
39. Strober M, DeAntonio M, Schmidt-Lackner S, Pataki C, Freeman R, Rigali J, and others. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. J Clin Psychiatry 1999;60:164-9.
40. Alderman J, Wolkow R, Chung M, Johnston HF. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry 1998;37:386-94.
41. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol 1996;6:165-75.
42. Jain U, Birmaher B, Garcia M, Al-shabbout M, Ryan N. Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992;2:259-65.
43. Tierney E, Joshi P, Illinas J, Rosenberg L, Riddle M. Sertraline for major depression in children and adolescents: preliminary clinical experience. J Child Adolesc Psychopharmacol 1995;5:13-27.
44. Bostic JQ, Prince J, Brown K, Place S. A retrospective study of citalopram in adolescents with depression. J Child Adolesc Psychopharmacol 2001;11:159-66.
45. Birmaher B, Waterman GS, Ryan ND, Perel J, McNabb J, Balach L, and others. Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression. J Am Acad Child Adolesc Psychiatry 1998;37:527-35.
46. Boulos CM, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N. Response to desipramine treatment in adolescent major depression. Psychopharmacol Bull 1991;27:59-65.
47. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM. A double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 1990;26:85-90.
48. Kramer A, Feiguine R. Clinical effects of amitriptyline in adolescent depression: a pilot study. J Am Acad Child Adolesc Psychiatry 1981;20:636-44.
49. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson B, and others. Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 1994;33:686-94.
50. Kye CH, Waterman GS, Ryan N, Birmaher B, Williamson DE, Iyengar S, and others. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent depression. J Am Acad Child Adolesc Psychiatry 1996;35:1139-44.
51. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, and others. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
52. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Carson SW, Sethuraman G. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 1997;154:668-73.
53. Ryan ND, Varma D. Child and adolescent mood disorders-experience with serotonin-based therapies. Biol Psychiatry 1998;44:336-40.
54. Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. Br Med J 1995;310:897-901.
55. Hazell P, O'Coneel D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents (Cochrane Review). The Cochrane Library, Issue 4. Oxford: Update Software; 2002.
56. Riddle M, Geller B, Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993;32:792-7.
57. Simeon J, Dinicola V, Ferguson B, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuro-Psychopharmacol Biol Psychiatry 1990;14:791-5.
58. Emslie G, Rush J, Weinberg W, Kowatch R, Hughes C, Carmody T, and others. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7.
59. Emslie G, Rush J, Weinberg W, Kowatch R, Carmody T, Mayes T. Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depress Anxiety 1998;7:32-9.
60. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, and others. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-15.
61. US Food and Drug Administration. FDA approves Prozac for pediatric use to treat depression and OCD. FDA Talk Paper 2003; January 3.
62. Milin RP. Paroxetine studied in adolescents with major depression. The Brown University Child and Adolescent Psychopharmacology Update 2000;2:6-7.
63. Mandoki MW, Tapia MR, Sumner GS, Parker JL. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 1997;33:149-54.
64. Braconnier A, Coent RL, Cohen D. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. J Am Acad Child Adolesc Psychiatry 2003;42:22-9.
65. Goodyer IM, Herbert J, Secher SM, Pearson J. Short-term outcome of major depression: I. Comorbidity and severity a presentation as predictors of persistent disorder. J Am Acad Child Adolesc Psychiatry 1997;36:179-87.
66. Riggs PD, Mikulick SK, Coffman LM, Crowley TJ. Fluoxetine in drug-dependent delinquents with major depression: an open trial. J Adolesc Child Psychopharmacol 1997;7:87-95.
67. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: A pilot study. Hum Psychopharmacol Clin Exp 2000;15:461-9.
68. Harrington R, Whittaker J, Shoebridge P. Psychological treatment of depression in children and adolescents. A review of treatment research. Br J Psychiatry 1998;173:291-8.
69. Reinecke MA, Ryan NE, DuBois DL. Cognitive-behavioural therapy of depression and depressive symptoms during adolescence: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 1998;37:26-34.
70. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, and others. A clinical psychotherapy trial for adolescent depression comparing cognitive, family and supportive therapy. Arch Gen Psychiatry 1997;54:877-85.
71. Brent DA, Kolko D, Birmaher B, Baugher M, Bridge J, Roth C, and others. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry 1998;37:906-14.
72. Brent DA, Kolko DJ, Birmaher B, Baugher M, Bridge J. A clinical trial for adolescent depression: predictors of additional treatment in the acute and follow-up phases of the trial. J Am Acad Child Adolesc Psychiatry 1999;38:263-70.
73. Birmaher B, Brent DA, Kolko D, Baugher M, Bridge J, Holder D, and others. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000;57:29-36.
74. Kroll L, Harrington R, Jayson D, Fraser J, Gowers S. Pilot study of continuation cognitive-behavioural therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1996;35:1156-61.
75. Lerner M, Clum G. Treatment of suicide ideators: a problem-solving approach. Behav Ther 1990;21:403-11.
76. Jayson D, Wood A, Kroll L, Fraser J, Harrington R. Which depressed patients respond to cognitive-behavioural treatment. J Am Acad Child Adolesc Psychiatry 1998;37:35-9.
77. Mufson L, Moreau D, Weissman MM, Wickramaratne P, Martin J, Samoilov A. Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): Phase I and II studies. J Am Acad Child Adolesc Psychiatry 1994;33:695-705.
78. Mufson L, Fairbanks J. Interpersonal psychotherapy for depressed adolescents: a one-year naturalistic follow-up study. J Am Acad Child Adolesc Psychiatry 1996;35:1145-55.
79. Mufson L, Weissman MM, Moreau D, Garfinkel R. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 1999;56:573-9.
80. Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol 1999;67:734-45.
81. Harrington R. Family-genetic findings in child and adolescent depressive disorders. Int Rev Psychiatry 1996;8:355-68.
82. Diamond GS, Reis BF, Diamond GM, Siqueland L, Isaacs L. Attachment-based family therapy for depressed adolescents: a treatment development study. J Am Acad Child Adolesc Psychiatry 2002;41:1190-6.
83. Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry 1997;154:595-602.
84. Health Canada. Important drug safety information: until further information is available, Paxil (paroxetine hydrochloride) should not be used in children and adolescents under 18 years of age. 2003; July 1-3.
85. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, and others. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Two randomized controlled trials. JAMA 2003;290:1033-41.